Track the SANUWAVE Health, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €42.7m. The latest transaction was reported on 30 April 2026 (Cession). Among the most active insiders: Opaleye Management Inc.. Every trade is openly available.
23
Insider Decl.
n/a
Thresholds
€177,011
3 ops.
Buy Volume
€8m
10 ops.
Sell Volume
23Σ signal
Buys €177,011€8m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 567 of 29,056 companies
84.0
score / 100
Value
87
Quality
81
FCF yld4.8%
Earn yld29%
EV/EBITDA3.3x
ROE·
Gross mgn77%
Net mgn27%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
71,875,000 shares@ US$0.0448.1% of flowCommon Stock, par value $0.001SEC:0000919574-23-004387:0
23 of 23 declarations
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. is a company focused on developing technologies for wound and pain treatment. It concentrates on innovative solutions to enhance tissue healing and cellular regeneration.